Lacosamide for pain

Expert Opinion on Investigational Drugs

Volumn 19, Issue 9, 2010, Pages 1129-1134

  McCleane, Gary ^a  

^a Rampark Pain Centre ^*  (United Kingdom)

Author keywords

Lacosamide; Neuropathic pain; Painful diabetic neuropathy

Indexed keywords

CARBAMAZEPINE; CYTOCHROME P450 2C19; GABAPENTIN; HARKOSERIDE; PHENYTOIN; PREGABALIN;

ANALGESIA; DIABETIC NEUROPATHY; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; LICENCE; NAUSEA; NEUROPATHIC PAIN; NONHUMAN; REVIEW;

ACETAMIDES; ANALGESICS; ANIMALS; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MALE; NEURALGIA; RATS;

EID: 77955600569     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.2010.511174     Document Type: Review

References (25)

1. Bergouignan M, D'Aulnay N. Effect of diphenyl-hydantoinate salt on essential trigeminal neuralgia. Rev Otoneuroophthalmol 1951;23:1202-1205
2. Murphy JP. Tegretol (carbamazepine): a new and effective medical treatment of trigeminal neuralgia, with a not concerning its use in the syndrome of thalamic hyperpathia. Med Ann Dist Columbia 1966;35:658-663
3. Lutz EG. Treatment of tic doloureaux with G-32883 (carbamazepine). Dis Nerv Syst 1966;27:600-603
4. Rockliff BW, Davis EH. Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol 1966;15:129-136
5. McQuay H, Tramer M, Nye BA, et al. A systematic review of antidepressants in neuropathic pain. Pain 1996;68:217-227
6. Errington AC, Stohr T, Heers C, Lees G. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol 2008;73:157-169
7. Sheets PL, Heers C, Stoehr T, Cummins TR. Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N- benzyl-3-methoxypropanamide], lidocaine, and carbamazepine. J Pharmacol Exp Ther 2008;326:89-99
8. Errington AC, Coyne L, Stohr T, et al. Seeking a mechanism of action for the novel anticonvulsant lacosamide. Neuropharmacology 2006;50:1016-1029
9. Beyreuther B, Callizot N, Stohr T. Antinociceptive efficacy of lacosamide in a rat model for peripheral diabetic neuropathy. Eur J Pharmacol 2006;539:64-70
10. Hao JX, Stohr T, Selve N, et al. Lacosamide, a new anti-epileptic, alleviates neuropathic pain like behaviours in rat models of spinal cord or trigeminal nerve injury. Eur J Pharmacol 2006;553:135-140
11. Bee LA, Dickenson AH. Effects of lacosamide, a novel sodium channel modulator on dorsal horn neuronal responses in a rat model of neuropathic pain. Neuropharmacology 2009;57:472-479
12. Stohr T, Krause E, Selve N. Lacosamide displays a potent antinociceptive effects in animal models for inflammatory pain. Eur J Pain 2006;10:241-249
13. Beyreuther B, Callizot N, Stohr T. Antinociceptive efficacy of lacosamide in the monosodium iodoacetate rat model for osteoarthritis pain. Arthritis Res Ther 2007;9:R14
14. Beyreuther BK, Geis C, Stohr T, Sommer C. Antihyperalgesic efficacy of lacosamide in a rat model fro muscle pain induced by TNF. Neuropharmacology 2007;52:1312-1317
15. Beyreuther BK, Callizot N, Brot MD, et al. Antinociceptive efficacy of lacosamide in rat models for tumor and chemotherapy-induced cancer pain. Eur J Pharmacol 2007;565:98-104 (Pubitemid 46782774)
16. McCleane G, Koch B, Rauschkolb C. Does SPM 927 have an analgesic effect in human neuropathic pain? Neurosci Lett 2003;352:117-120
17. Rauck RL, Shaibani A, Biton V, et al. Lacosamide in painful diabetic peripheral neuropathy: a phase II double-blind placebo-controlled study. Clin J Pain 2007;23:150-158
18. Wymer JP, Simpson J, Sen D, Bongardt S; Lacosamide SP742 Study Group. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed dose regimens. Clin J Pain 2009;25:376-385
19. Shaibani A, Fares S, Selam JL, et al. Lacosamide in painful diabetic neuropathy: an 18-week double blind placebo controlled trial. J Pain 2009;10:818-828
20. Ziegler D, Hidvegi T, Gurieva I, et al. Efficacy and safety of lacosamide in painful diabetic neuropathy. Diabetes Care 2010;33:839-841
21. Shaibani A, Biton V, Rauck R, et al. Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial. Eur J Pain 2009;13:458-463
22. Biton V. Lacosamide for the treatment of diabetic neuropathic pain. Expert Rev Neurother 2008;8:1649-1660
23. European Medicines Agency. Questions and answers on the withdrawal of the marketing application for Lacosamide Pain UCB Pharma. London: Doc.Ref. EMEA/522632/2008
24. Wiffen PJ, Collins S, McQuay HJ, et al. Cochrane Database Syst Rev 2010;1:CD001133
25. Moore RA, Straube S, Wiffen PJ, et al. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev 2009;3:CD007076